GlassScriptPhysician profile
Ashley Hagen
NPI 1518482165
$1,599.36
in general payments reported to CMS, 2019-2025
22 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.80 · 2024: $15.56 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,561.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $175.80 | 2025 | |
| Dexcom, INC. | $152.65 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $138.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $134.29 | 2025 | |
| Abbvie INC. | $125.93 | 2025 | |
| Genzyme Corporation | $119.84 | 2025 | |
| Exact Sciences Corporation | $119.84 | 2025 | The Cologuard Plus Collection Kit |
| Dendreon Pharmaceuticals LLC | $100.30 | 2025 | Provenge |
| Vertex Pharmaceuticals Incorporated | $92.63 | 2025 | |
| Janssen Biotech, INC. | $89.53 | 2025 | Erleada |
| Urogen Pharma, INC. | $51.14 | 2025 | |
| Procept Biorobotics Corporation | $42.62 | 2025 | |
| Gilead Sciences, INC. | $37.80 | 2021 | |
| Ferring Pharmaceuticals INC. | $36.79 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $35.20 | 2025 | Lynparza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.94 | 2025 | Keytruda |
| 180 Medical, INC. | $28.86 | 2025 | |
| Endo USA, INC. | $22.62 | 2025 | Xiaflex |
| Tolmar, INC. | $20.95 | 2025 | Eligard, Jatenzo |
| Otsuka America Pharmaceutical, INC. | $15.56 | 2024 | Abilify Maintena, Abilify Asimtufii |
| Sun Pharmaceutical Industries INC. | $14.91 | 2025 | |
| Cycle Pharmaceuticals INC | $14.38 | 2025 | Venxxiva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hagen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.